Rezultaty - David M. Charytan
- Rezultaty 1 - 20 Rezultaty od 64
- Idź do następnej strony
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria od Hikaru Sugimoto, Yuki Hamano, David M. Charytan, Dominic Cosgrove, Mark W. Kieran, Akulapalli Sudhakar, Raghu Kalluri
Wydane 2003Artigo -
10
-
11
-
12
-
13
-
14
-
15
-
16
Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis od Alexandre Leszek, Lauriane Poli, Stéphanie Zbinden, Lucas C. Godoy, Jean‐Luc Reny, Michael E. Farkouh, David M. Charytan, Thomas A. Mavrakanas
Wydane 2022Revisão -
17
-
18
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy od Javid J. Moslehi, Yoji Andrew Minamishima, Jianru Shi, Donna Neuberg, David M. Charytan, Robert F. Padera, Sabina Signoretti, Ronglih Liao, William G. Kaelin
Wydane 2010Artigo -
19
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidne... od David M. Charytan, Robert F. Padera, Alexander M. Helfand, Michael Zeisberg, Xingbo Xu, Xiaopeng Liu, Jonathan Himmelfarb, Angeles Cinelli, Raghu Kalluri, Elisabeth M. Zeisberg
Wydane 2014Artigo -
20
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Kidney disease
Cardiology
Intensive care medicine
Endocrinology
Diabetes mellitus
Myocardial infarction
Renal function
Type 2 diabetes
Dialysis
Confidence interval
Canagliflozin
Coronary artery disease
Disease
Hazard ratio
Randomized controlled trial
Heart failure
Pathology
Urology
Alternative medicine
Environmental health
Placebo
Population
Hemodialysis
Acute kidney injury
Albuminuria
Biology
Clinical trial
Engineering